Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: VORMI1N8H9S4F1 N8H9S4F1 ×

VORMI1N8H9S4F1 N8H9S4F1

This drug is selected. Its supporting articles are shown below.

VORMI1N8H9S4F1 N8H9S4F11

Articles mentioning VORMI1N8H9S4F1 N8H9S4F1

1 articles · page 1 of 1

PO:02:044 Glycomic profiles of IgG, C3 and alpha-1-acid glycoprotein (AGP) before and one year after treatment commenced for active lupus nephritis

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

76.0%

VORMI1N8H9S4F1 N8H9S4F1 Lupus nephritis systemic lupus erythematosus LN

…S4 N8H9S4 (r=0.51, P=0.029; r=0.49, P=0.038, respectively), and VORMI1N8H9S4F1 N8H9S4F1 (r=0.48, P=0.039; r=0.49, P=0.034, respectively) significantly …

Browse drugs

VORMI1N8H9S4F1 N8H9S4F1

Articles mentioning VORMI1N8H9S4F1 N8H9S4F1

PO:02:044 Glycomic profiles of IgG, C3 and alpha-1-acid glycoprotein (AGP) before and one year after treatment commenced for active lupus nephritis